Does timing matter? Upstream or downstream administration of antiplatelet therapy

Mehta, 2006, Recent trends in the care of patients with non–ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative, Arch Intern Med, 166, 2027, 10.1001/archinte.166.18.2027 Anderson, 2007, J Am Coll Cardiol, 50, e1, 10.1016/j.jacc.2007.02.013 Topol, 2000, Recognition of the importance of embolization in atherosclerotic vascular disease, Circulation, 101, 570, 10.1161/01.CIR.101.5.570 Diercks, 2004, Derivation and validation of a risk stratification model to identify coronary artery disease in women who present to the emergency department with potential acute coronary syndromes, Acad Emerg Med, 11, 630, 10.1111/j.1553-2712.2004.tb02405.x Fox, 2006, Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE), Br Med J, 333, 1091, 10.1136/bmj.38985.646481.55 Eagle, 2004, A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry, JAMA, 291, 2727, 10.1001/jama.291.22.2727 Fesmire, 2002, The Erlanger Chest Pain Evaluation Protocol: a one-year experience with serial 12-lead ECG monitoring, two-hour delta serum marker measurements, and selective nuclear stress testing to identify and exclude acute coronary syndromes, Ann Emerg Med, 40, 584, 10.1067/mem.2002.129506 Jaffery, 2007, Modified Thrombolysis in Myocardial Infarction (TIMI) risk score to risk stratify patients in the emergency department with possible acute coronary syndrome, J Thromb Thrombolysis, 24, 137, 10.1007/s11239-007-0013-0 Pollack, 2006, Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population, Acad Emerg Med, 13, 13, 10.1111/j.1553-2712.2006.tb00978.x Sanchis, 2005, New risk score for patients with acute chest pain, non–ST-segment deviation, and normal troponin concentrations: a comparison with the TIMI risk score, J Am Coll Cardiol, 46, 443, 10.1016/j.jacc.2005.04.037 Antman, 2000, The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making, JAMA, 284, 835, 10.1001/jama.284.7.835 Ohman, 1996, Cardiac troponin T levels for risk stratification in acute myocardial ischemia, N Engl J Med, 335, 1333, 10.1056/NEJM199610313351801 Antman, 1996, Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes, N Engl J Med, 335, 1342, 10.1056/NEJM199610313351802 Fesmire, 2006, Clinical policy: critical issues in the evaluation and management of adult patients with non–ST-segment elevation acute coronary syndromes, Ann Emerg Med, 48, 270, 10.1016/j.annemergmed.2006.07.005 Savonitto, 1999, Prognostic value of the admission electrocardiogram in acute coronary syndromes, JAMA, 281, 707, 10.1001/jama.281.8.707 Rao, 2005, Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes, Am J Cardiol, 96, 1200, 10.1016/j.amjcard.2005.06.056 Kinnaird, 2003, Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions, Am J Cardiol, 92, 930, 10.1016/S0002-9149(03)00972-X Chew, 2005, Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial), Am J Cardiol, 95, 581, 10.1016/j.amjcard.2004.11.003 Sadeghi, 2003, Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction, Circulation, 108, 2769, 10.1161/01.CIR.0000103623.63687.21 Moscucci, 2003, Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE), Eur Heart J, 24, 1815, 10.1016/S0195-668X(03)00485-8 Eikelboom, 2006, Adverse impact of bleeding on prognosis in patients with acute coronary syndromes, Circulation, 114, 774, 10.1161/CIRCULATIONAHA.106.612812 Mehta, 2006, Differences in the clinical features and outcomes in African Americans and whites with myocardial infarction, Am J Med, 119, 70.e71, 10.1016/j.amjmed.2005.07.043 Alexander, 2005, Excess dosing of antiplatelet and antithrombin agents in the treatment of non–ST-segment elevation acute coronary syndromes, JAMA, 294, 3108, 10.1001/jama.294.24.3108 Kirtane, 2006, Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial, J Am Coll Cardiol, 4, 2374, 10.1016/j.jacc.2005.09.080 Szczesiul, 2007, Use of clinical pharmacists in the academic EDs is limited, Acad Emerg Med, 14, S87, 10.1197/j.aem.2007.03.944 Hillebrand, 2007, Medical and nursing staff highly value clinical pharmacists in the ED, Acad Emerg Med, 14, S200, 10.1197/j.aem.2007.03.1282 Rudis, 2007, Drug related problems (DRPs) in the emergency department (ED): clinical pharmacists improve detection of medication non-adherence, Acad Emerg Med, 14, S200, 10.1197/j.aem.2007.03.1281 Boersma, 2002, Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials, Lancet, 359, 189, 10.1016/S0140-6736(02)07442-1 Kastrati, 2004, A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel, N Engl J Med, 350, 232, 10.1056/NEJMoa031859 Kastrati, 2006, Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial, JAMA, 295, 1531, 10.1001/jama.295.13.joc60034 Stone, 2006, Bivalirudin for patients with acute coronary syndrome, N Engl J Med, 355, 2203, 10.1056/NEJMoa062437 SYNERGY Trial Investigators, 2004, Enoxaparin vs unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial, JAMA, 292, 45, 10.1001/jama.292.1.45 Bertrand, 2002, Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation, Eur Heart J, 23, 1809, 10.1053/euhj.2002.3385 Hoekstra, 2005, Early glycoprotein IIb/IIIa inhibitor use for non–ST-segment elevation acute coronary syndrome: patient selection and associated treatment patterns, Acad Emerg Med, 12, 431, 10.1197/j.aem.2004.11.029 Boersma, 1999, Platelet glycoprotein IIb/IIIa receptor inhibition in non–ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention, Circulation, 100, 2045, 10.1161/01.CIR.100.20.2045 Peterson, 2003, Early use of glycoprotein IIb/IIIa inhibitors in non–ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4, J Am Coll Cardiol, 42, 45, 10.1016/S0735-1097(03)00514-X Stone, 2007, Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing Trial, JAMA, 297, 591, 10.1001/jama.297.6.591 Giugliano, 2005, Am Heart J, 149, 994, 10.1016/j.ahj.2005.03.029 Yusuf, 2001, Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N Engl J Med, 345, 494, 10.1056/NEJMoa010746 Yusuf, 2003, Early and late effects of clopidogrel in patients with acute coronary syndromes, Circulation, 107, 966, 10.1161/01.CIR.0000051362.96946.15 Mehta, 2001, Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study, Lancet, 358, 527, 10.1016/S0140-6736(01)05701-4 2007, Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Guidelines for the diagnosis and treatment of non–ST-segment elevation acute coronary syndromes, Eur Heart J, 28, 1598, 10.1093/eurheartj/ehm161 Mehta, 2006, Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non–ST-segment elevation acute coronary syndromes, Am J Cardiol, 98, 624, 10.1016/j.amjcard.2006.03.040 Sadanandan, 2004, A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non–ST-segment elevation myocardial infarction, J Am Coll Cardiol, 44, 799, 10.1016/j.jacc.2004.03.081 Pollack, 2003, 2002 update to the ACC/AHA guidelines for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction: implications for emergency department practice, Ann Emerg Med, 41, 355, 10.1067/mem.2003.88